A new pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease.It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).Pfizer says it stopped trials early as the initial results were so positive.
The UK has already ordered 250,000 courses of the new Pfizer treatment, which has not yet been approved, along with another 480,000 courses of MSD's molnupiravir pill.
Health and Social Care Secretary Sajid Javid called the results "incredible", and said the UK's medicines regulator would now assess its safety and effectiveness.
- Forums
- ASX - By Stock
- PAA
- The Home Stretch
The Home Stretch, page-213
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $89.08M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 22.0¢ | $170.5K | 749.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34313 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 24444 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9313 | 0.225 |
1 | 92000 | 0.220 |
5 | 50744 | 0.215 |
3 | 26203 | 0.210 |
4 | 27155 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 24444 | 2 |
0.240 | 25628 | 2 |
0.245 | 78609 | 3 |
0.250 | 65920 | 6 |
0.255 | 120000 | 2 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
22.5¢ |
  |
Change
-0.010 ( 6.25 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 22.0¢ | 246904 | ||
Last updated 15.57pm 14/06/2024 ? |
Featured News
PAA (ASX) Chart |